Carbapenems are the b-lactam agents of choice for infections due to extendedspectrum b-lactamase (ESBL)-producing members of the Enterobacteriaceae, but carbapenem-non-susceptible members of the Enterobacteriaceae are increasingly reported worldwide (Nordmann et al., 2011) .
Resistance to carbapenems is mediated by carbapenemases such as the Ambler metallo-b-lactamases belonging to class B (VIM, IMP and NDM types), class A (KPC and GES) and class D (OXA-48) (Nordmann, 1998) . Carbapenem nonsusceptibility may also be due to ESBL or cephalosporinase hyperproduction associated with decreased permeability (Jacoby et al., 2004; Nordmann et al., 2009) .
Rapid detection of carbapenem-resistant members of the Enterobacteriaceae is crucial for infection control, development of measures to limit the spread of these pathogens, and optimal antibiotic therapy. Indeed, patients with unrecognized colonization by carbapenemase-producing members of the Enterobacteriaceae have been shown to serve as reservoirs for transmission during health-care-associated outbreaks (Samra et al., 2007) .
Here we evaluated a novel carbapenemcontaining screening medium, Brilliance CRE (Oxoid), for the detection of carbapenem-non-susceptible members of the Enterobacteriaceae by testing it against 32 isolates from our own strain collection (Table 1) . Forty-four carbapenemsusceptible ESBL-producing members of the Enterobacteriaceae were also tested for comparison (Table 1 ). All the strains had previously been characterized for blactamase expression at the molecular level.
The carbapenem-resistant strains were KPC (n57), VIM (n54), or NDM-1 (n53) producers, high-level cephalosporinase producers (n54) or ESBL producers (n56) with decreased permeability and one strain was a highlevel cephalosporinase and ESBL producer also exhibiting decreased permeability. 
